BetterLife Pharma (BETRF) Enterprise Value (2011 - 2026)

BetterLife Pharma has reported Enterprise Value for 16 years, with the latest figure at $10.0 million in Q2 2026.

• On a quarterly basis, Enterprise Value fell 9.7% year-over-year to $10.0 million in Q2 2026; TTM through Apr 2026 was $10.0 million, a 9.7% decrease from a year earlier, with the FY2026 full-year figure at $8.4 million, down 45.56% from the prior year.
• Enterprise Value was $10.0 million for Q2 2026 at BetterLife Pharma, up from $8.4 million in the prior quarter.
• The five-year high for Enterprise Value was $15.4 million in Q1 2025, with the low at $6.1 million in Q4 2023.
• Average Enterprise Value over 5 years is $10.6 million, with a median of $10.6 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Enterprise Value surged 196.68% in 2022, then plunged 53.15% in 2023.
• Over 5 years, Enterprise Value stood at $13.0 million in 2022, then slumped by 53.15% to $6.1 million in 2023, then soared by 74.13% to $10.6 million in 2024, then grew by 18.29% to $12.6 million in 2025, then fell by 20.68% to $10.0 million in 2026.
• The last three Enterprise Value figures came in at $10.0 million (Q2 2026), $8.4 million (Q1 2026), and $12.6 million (Q3 2025), per Business Quant data.